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Cats vs. Dogs: The Efficacy of
Feliway FriendsTM and AdaptilTM
Products in Multispecies Homes
Miriam Rebecca Prior* and Daniel Simon Mills
Animal Behaviour Cognition and Welfare Group, School of Life Sciences, University of Lincoln, Lincoln, United Kingdom
Seven percent of UK households are estimated to own both a cat and a dog, despite a
popular view that the two do not live well together. This is the first study to evaluate the
effects of pheromone products Feliway FriendsTM and AdaptilTM on cat-dog interactions,
in homes where owners perceived the potential for improvement in the relationship
between their cat and dog. A blinded parallel randomized trial design over a 6-week
period was used to evaluate the effect of each of the two products, with 17 participants in
each group completing the trial. Owners reported weekly on the frequency of 10 specific
undesirable interactions and seven specific desirable interactions. Total undesirable
and desirable interaction scores both showed significant linear contrasts over time
(undesirable score decreased; desirable score increased). Undesirable interaction scores
were significantly lower (with a very large effect size) during treatment compared with
baseline. There were no significant differences between the two pheromone products
in relation to these outcome measures. AdaptilTM and Feliway FriendsTM were both
associated with a significant decrease in: dog chasing cat/cat runs away; cat hiding
from dog; cat/dog staring at the other; and dog barking at cat. With AdaptilTM a
significant increase was also seen in: friendly greeting and times spent relaxed in the
same room. From baseline (Week 2) to the end of the study (Week 6) there was a
significant improvement in owners’ perception of dog relaxation in those participants
who received AdaptilTM and of cat relaxation in those participants who received Feliway
FriendsTM. Similarity in the core chemical structure of the appeasing pheromones might
explain the main effects, whilst different species-specific additions may explain the
product-appropriate species-specific increases in relaxation scores. Specific behavioral
improvements seen with AdaptilTM may reflect a greater calming of dogs in this group,
reducing their interest in seeking interaction with cats in the same home and the tension
in the cat as a result. In conclusion, both products appear to improve the cat-dog
relationship and it would be beneficial to further study their use in combination and against
placebo. If selecting one product AdaptilTM may be preferable, unless there is a particular
need to increase the cat’s relaxation.
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INTRODUCTION
Cats and dogs are the most popular pets, with an estimated
8.5 million pet dogs and 8 million pet cats in residence in the
UK: 24% of UK households have at least one dog and 17%
have at least one cat (1). These figures are not exceptional with
global estimates of household dog ownership reported in the USA
at 36.1%, Costa Rica at 53%, Sydney, Australia at 33.4%; and
Teramo, Italy at 33%, with cat ownership in the USA at 31.6%;
Costa Rica at 15%, Sydney, Australia at 22.5% and Teramo,
Italy at 15% (2–5). Multi-species households are also increasingly
common with recent estimates suggesting: 7% of UK households
own both a cat and a dog; likewise, 7.8% of residents of Sydney,
Australia, owned both species; and 7% of the residents of Teramo,
Italy, owned both species (4–6).
Despite the prevalence of multi-species households across
the globe, there has been little research to date on cats’
and dogs’ relationships with one another. Feuerstein and
Terkel (7) highlight the suspected difficulty inherent in cat-dog
communication; a stereotype that has permeated popular culture
and is exemplified in the media by shows such as Nickelodeon’s
“CatDog,” Warner Bros. “Cats & Dogs” (2001), and Spike the
dog in MGM’s cartoon “Tom and Jerry”. Challenges in the cat-
dog relationship can arise as a result of their differing behavioral
tendencies and differences in typical social structure, for example
cats lack a widely understood deference signal unlike dogs, and
appear to place little importance on any observed hierarchy
when determining access to key resources (8). Cats may also be
seen as prey to some dogs, particularly those bred for hunting
smaller mammals such as sighthounds or terriers. Feuerstein
and Terkel (7) identified four behavioral categories in which
the conveyed message is contradictory when performed by a cat
compared with a dog: the horizontal full tail wag; stretching out
forefeet; laying on back; and turning head away, all of which they
consider to be appeasing/submissive signals in dogs but signs
of frustration/aggression in cats. Despite these differences, cats
and dogs are often able to form amicable relationships and most
pet owners believe that their cat and dog are comfortable in
each-other’s presence (7, 9).
However, a poor relationship between a resident cat and
dog can have serious consequences for the welfare of individual
animals. There may be an unacceptable level of social stress or
restricted access to key resources such as food, water or suitable
toilet areas. There will also be increased stress for the remainder
of the family (both human and animal), and potential risks of
injury due to conflict. Importantly, it has been reported that
a problematic relationship between a new pet and an existing
pet is one of the top ten behavioral reasons for relinquishment
to shelters for both cats and dogs (10). Whilst this latter study
did not specify the percentage of cases in which problematic
relationships were same-species or cat-dog relationships, the
authors did specify that where cats were relinquished following
acquisition of a dog in the previous year, they were much
more likely to be relinquished for behavioral rather than non-
behavioral reasons.
Pheromone-related products are believed to affect the
emotional processing of animals that can detect them and
are in widespread use as environmental adjuncts to aid in
behavioral problems associated with stress and the perception of a
stressful environment (11). In 1996, Feliway ClassicTM, utilizing a
synthetic version of the cat F3 facial-marking pheromone, was the
first pheromone product for companion animals to be launched.
AdaptilTM, based on the Dog Appeasing Pheromone (DAP)
was launched in 2000, and Feliway FriendsTM (a.k.a Feliway
MultiCatTM in the USA) based on the Cat Appeasing Pheromone
(CAP), was launched in 2016 (12).
The mammary region is the natural origin of the appeasing
pheromone, being secreted from around 3–4 days after
parturition until 2–5 days after weaning. Appeasing pheromones
are believed to provide reassurance to offspring that persists
even in the absence of a maternal figure (13). It is hypothesized
that the presence of this mixture in the environment encourages
offspring to remain calm while the mother hunts but also helps
to identify safe areas to explore as the young develop and become
more independent. The appeasing pheromones thus serve as an
environmental signal that encourages a bias toward perceiving
things as safe.
The different appeasing pheromone products (AdaptilTM and
Feliway FriendsTM) contain some common fatty acids but also
species-specific elements. Similar ratios of oleic acid, palmitic
acid, and linoleic acid make up the generalized mammalian
appeasing message, but it is suggested that additional species-
specific components increase species-specific efficacy (13).
Evidence in support of the reassuring effect of DAP in dogs
comes from data relating to a reduction in barking in shelter
environments; separation related behaviors; firework fears; and
anxiety at the veterinary clinic; as well as improved socialization
in puppies (14–18). The quality of published research evidence in
support of all of these indications is variable, as is the quality of
some of the criticisms made concerning the evidence base. For
example, the skeptical review of Frank et al. (19) is often cited
in the context of an “evidence-based argument” [e.g., (20, 21)]
without equal consideration given to the flaws in this latter work
which have been highlighted by both Pageat et al. (22) and Beck
(23) in the same journal. Both proponents and opponents to the
use of pheromones may selectively cite the literature in favor of
their case.
There are very few peer reviewed studies on CAP, however
initial results are potentially promising regarding its use in
reducing inter-cat conflict in multi-cat households. A case report
on the use of Feliway FriendsTM in a single multi-cat household
documents increased cat-cat proximity, increased tolerance,
faster recovery following aversive encounters, and increased
duration of sleeping in proximity between cohabiting pairs of
cats (24). A randomized, double-blind placebo controlled study
of 45 households claims a greater decrease in aggression scores
with Feliway FriendsTM compared with placebo (25). This study
is described as a “pilot study” perhaps because an atypical
significance threshold was chosen to illustrate a more consistent
effect across time, although a conventional significance threshold
(p < 0.05) would still indicate superiority of the pheromone
product over placebo at days 21 and 42. The consistent positive
outcome in these circumstances, as well as the specific behavior
changes seen in each context, support the hypothesis that CAP
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also creates some form of bias toward an increased sense of safety
in the environment.
It is worth noting that pheromone products are intended
for use as an environmental adjunct to aid relaxation. As
pheromone products only form part of the environmental
input processed by an individal they can be counteracted by
more overt threatening cues, and this might explain why, for
many behavioral problems, they are generally recommended
in combination with a behavioral modification plan. This may
include psychopharmacological intervention when addressing an
established behavior problem.
Both AdaptilTM and Feliway FriendsTM are described as
appeasing pheromones due to their origin and compositional
similarities, but currently Feliway FriendsTM is specifically
marketed for conflicts and aggression whereas AdaptilTM has
never been evaluated for use in conflict and is not promoted for
use in these circumstances (26). The reason behind the different
recommendations of these apparently similar products is not
clear, but may be based on an assessment of risk and differences
in typical cat and dog social behavior, with cats typically being
more avoidant and exclusionary than dogs.
Within the cat-dog relationship, the behavior of the cat may
be particularly important. A recent study of 748 mixed species
homes found that cats were observed to be uncomfortable with
dogs or to threaten dogs more frequently than vice versa (9). The
study concluded that “comfortability of the cat” was the most
important prognostic indicator of the cat-dog relationship (9),
however no indication was given as to whether it is the cat’s
temperament and behavior which underpins its comfortability,
or the dog’s. Given thatmany cats and dogs appear to live together
in a state of some tension, but not deep hostility, this situation
provides an excellent context in which to evaluate the effect and
species-specificity of CAP and DAP, without other behavioral
intervention. However, given the lack of information about the
nature of the determinants of “cat comfortability” it was not
possible to predict which product may be better.
To date there has been no scientific study investigating the
potential efficacy of pheromone products in improving the cat-
dog relationship in multi-species homes. Therefore, the aim of
the current study was to undertake a blinded parallel randomized
trial to evaluate and compare the effects of AdaptilTM and
Feliway FriendsTM on the cat-dog relationship in multi-species
households where there was some tension in the relationship
between the two species. It was hypothesized that both products
would improve the cat-dog relationship, but that there should
be some differences between the two products given their
different compositions. No a priori assumptions were made as to
specific effects.
MATERIALS AND METHODS
Ethical approval for the study was provided by the delegated
authority of the University of Lincoln’s College of Science
Ethics Committee.
Given the limited previous research on the cat-dog
relationship, it was necessary first to design an appropriate
survey instrument to capture the clinically important details of
the relationship, before undertaking the double blinded parallel
randomized study.
Design of Survey Instrument
Focus groups were used to capture the details of the cat-
dog relationship that pet owners felt were most important.
Separate focus groups were used to discuss cat behaviors and
dog behaviors. The focus groups followed a basic template with
group discussion encouraged after each question was asked (for
template see Supplementary Material Table 4). Groups ran until
redundancy on this topic was achieved (two rounds of focus
groups for each species). Transcripts were analyzed and behaviors
that were consistently considered to be important indicators
of the relationship were identified from their frequency within
and between groups. The focus groups recruited individuals
with a special interest in the veterinary and/or behavior fields.
For the veterinary group, inclusion criteria were ownership of
both cat(s) and dog(s) and employment at a veterinary practice.
For the behavior group, inclusion criteria were ownership of
both cat(s) and dog(s) and at least an MSc level qualification
in Clinical Animal Behavior. In order to ensure that the
themes which emerged from these were understood by non-
specialists, a comprehension assessment was undertaken using
an interactive PowerPoint survey of the issues raised (27).
This presentation was distributed to six volunteer members of
the general public recruited through social media. Specifically,
these “lay-volunteers” did not work in an animal-related
profession or consider themselves to be experts in the field.
These volunteers were also given the opportunity to raise
any further issues that may have been missed by the expert
focus groups. No further issues were raised. Based on the data
collected from these activities a 34-item survey was created (See
Supplementary Material Table 1). Seventeen items (10 relating
to undesirable interactions and seven to desirable interactions)
assessed the frequency of specific cat-dog interactions. The
ten undesirable interactions were: cat blocking dog’s path; dog
chasing cat/cat running away (not in play); dog growling at
cat; cat hiding from dog or up high; staring; cat swiping at
dog; dog barking at cat; cat hissing at dog; dog interrupting
fuss of cat (i.e., approaching and causing disruption when the
owners fuss the cat); and cat interrupting fuss of dog. The seven
desirable interactions were: playing (both pets enjoying play
together); sleeping near each other; dog grooming cat; friendly
greeting; cat grooming dog; sharing a bed; and both relaxed in
the same room. All of these were scored by the owner using a
5-point Likert frequency scale (Several times a day, Daily, 3–6
times this week, 1–2 times this week, Not this week). Additional
items assessed cat comfortability, dog comfortability (both scored
subjectively by the owner out of ten), changes in owner routine,
and only for households with additional pets, the behavior of
these other animals in the household, especially in relation to the
focal subjects.
Parallel Randomized Trial (PRT)
Participants for the PRT were recruited using online groups,
social media, and poster advertisements in the waiting rooms of
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veterinary practices. Criteria for inclusion were that participants
had to: be 18 years of age or older; own at least one dog and one
cat, each of which spend >40% of their time in the home; feel
that there was room for improvement in the relationship between
one of their dogs and one of their cats; have a 6 week period in
which to complete the trial with no holidays or changes in routine
planned; and be willing to complete surveys on a weekly basis.
Participants also had to confirm that in the 3 months prior to the
trial they had not moved to a new house; nor acquired any new
pets; nor started treating their pets with any medications which
could influence behavior; nor used any AdaptilTM or Feliway
FriendsTM products.
During an initial telephone interview, qualitative information
was collected describing the cat-dog relationships in each
household based on a pre-defined list of questions but with room
for owner elaboration. On this basis, the participant’s animals’
relationships were categorized into the following groups: dog
interested—cat fearful; cat interested—dog fearful; indifferent;
and avoidant. A suitable location for diffuser placement was
also identified at this time: a floor-level plug socket in an area
frequented by both pets and not obstructed by furniture or
close to open windows/doors. Subjects were then allocated a
diffuser based on order of recruitment. All diffusers were visually
identical and randomly allocated a number for order of use, in
batches of 10 (five of each product). The researchers were blind
to the treatment groups as this process was undertaken by an
individual otherwise independent of the study.
Data concerning the frequency of specific cat-dog interactions
and a score of the owner’s perception of their pets’ overall level
of relaxation were collected weekly using the survey instrument
(Supplementary Material Table 1). Two weeks of baseline data
were captured since it was thought that owners’ observation
abilities and thus perceptions of the problem might change with
the introduction of the recording sheet. Diffusers were posted to
each participant in time for them to be plugged in immediately
after completion of the second “baseline” week survey.
Immediately after completion of the second week baseline
survey, owners were instructed to plug in the diffuser which they
had now been allocated, and surveys were completed weekly for a
further 4 weeks. All trials were completed between 29th October
2018 to 5th March 2019.
Initial participant groupings (A vs. B) were revealed to the
researchers only after all data had been gathered in order to
eliminate the risk of bias during the trial. The researchers
remained blinded to the specific identity of the groups (i.e., which
product each group had received) until all statistical analysis
was complete.
The primary outcome of interest was a change in total
undesirable interactions over the test period, with the expectation
that these would decrease with pheromone diffuser use. The
total undesirable interaction score was calculated as the sum
of the Likert-scale scores (0–4 for each) of the 10 undesirable
interactions. The secondary outcome of interest was change in
total desirable interactions, which were expected to increase with
diffuser use. The total desirable interaction score was calculated
in a similar way. Evaluation of specific behaviors making up each
of these scores was only of interest if there was a significant
change in these total scores. Additional outcome measures
of interest discussed in this paper are “cat relaxation” and
“dog relaxation.” Data from the survey relating to the animals’
interactions with the owner or wider demeanor are not presented
here as they do not relate to the primary question of interest.
Unsolicited qualitative feedback from the owners was also
collated in order to gain a deeper insight into any issues arising.
Statistical Analysis
Analysis was conducted using IBM SPSS version 25 forWindows.
A data management and statistical analysis plan for the
undesirable and desirable interaction outcomes was developed
a priori as follows. Where <5% of data throughout the study
was missing for a participant, estimated data were manually
imputed based on the average of the values for that variable at the
time points immediately before and after the missing time point
for that subject. Any participant with more than 5% missing
data would have been excluded, but this did not occur: missing
responses were infrequent and there were only eight missing
data points out of a total of the 3,876 recorded (0.2%
missing data).
Demographic data were assessed for significant difference
between the two groups using chi squared tests of association
for categorical data and Mann-Whitney U tests for measures of
duration (age of pets and duration of cohabitation).
For the primary outcome measure, total undesirable
interaction scores, data were checked for normality and a
repeated measures mixed ANOVA was used accordingly with
week and treatment group together with their interaction as
fixed factors (28, 29). Greenhouse-Geisser corrections were
employed to correct for a lack of sphericity. In order to identify
the source of differences for significant results post-hoc testing
was undertaken using pairwise comparisons. For interpretive
purposes, effect sizes were calculated (Partial eta squared).
Further testing to identify which specific behaviors were
potentially contributing to the overall change was undertaken
by comparing Week 2 scores (last baseline period) with Week 6
scores (end of treatment) for individual behaviors. Week 2 was
chosen as a point of reference, since it was felt that this would
provide amore conservative estimate, given the potential changes
in owner perception while learning to use the weekly survey
sheets. This comparison was undertaken using non-parametric
tests on each of the 10 undesirable behaviors. In accordance
with Feise (30) corrections for multiple testing were not made
in the individual behavior analysis as this was designed to help
elucidate where significant effects might lie and the risk of being
overly conservative was considered to outweigh the risks of false-
positive results at this stage of the analysis. To determine if there
was a difference between the scores of these items for the two
baseline weeks (Weeks 1 and 2), within subjects Wilcoxon tests
were used, without correction for multiple testing.
A similar statistical procedure was then used for the secondary
outcome measure, desirable interaction scores, with a repeated
measures mixed ANOVA used for assessment of total desirable
interaction scores followed by non-parametric assessment of
individual behavior frequencies.
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Since there were two outcomes of interest (desirable and
undesirable behavior) the significance threshold for evaluation of
each of the related ANOVA models was subject to a Bonferroni
correction, and revised to p < 0.025.
Data relating to the scoring of comfortability were not
normally distributed and so were analyzed using non-parametric
analyses. In order to reduce the number of analyses undertaken
we considered only the data from the second baseline week
(Week 2) and the final treatment week of the study (Week 6).
Wilcoxon T-tests for within group analysis with a significance
threshold of p < 0.025 were used for interpretative purposes
given the simultaneous evaluation of two outcomes (relaxation
of cat and relaxation of dog).
RESULTS
Thirty-six participants were enrolled onto the trial, of which two
participants failed to complete the trial: one due to acquisition
of a new pet, one due to loss of an existing pet during the
trial period, leaving 34 subjects for analysis. Details of the
data generated at each stage of the study are given in the
CONSORT Flowchart in Supplementary Material Table 2. Data
are reported only for those subjects remaining in the final
analysis. Unsolicited, qualitative comments received in emails
alongside the survey responses were generally positive and
included: “less chasing and more gentle play”; “my dog was
his usual pesky self but the cats were much more chilled with
each other and with him”; “the whole household has been more
content”; “I have seen (the cat and dog) touch noses a few times
which is definitely a new thing”; and “I will be going out to
purchase one of each of the diffusers until your results are in.”
One participant highlighted a consistent increased proximity
between her dog and cat which she felt was not adequately
captured by the survey: whilst the cat and dog had always been
relaxed in the same room of an evening, the cat historically
always chose to sit on a cat tower but following diffuser use
began to regularly sit on the edge of the sofa nearer to the
dog. There were also reports of behavioral changes not directly
related to the cat-dog relationship: a dog reported to be much
calmer on walks; and another dog that had always been fearful
of males taking treats after a couple of hours where previously
he had been reported to hide for most of the day if male
visitors arrived.
Participant Demographics
Results are summarized in Tables 1 and 2.
There were no significant differences between the two
diffuser groups in the number of pets per household
(multi-cat/multi-dog/both, all p > 0.2), the sex of pets
(dogs, p = 0.47, cats, p = 0.73) or the neuter status of
pets (p= 0.42).
There were no significant differences between the groups in
age of cat, age of dog or duration cohabiting (all p > 0.5).
Data relating to changes in total desirable and undesirable
interaction scores across the weeks of the study are summarized
in Table 3, with main effects described in the following sections.
TABLE 1 | Participant demographics.
Adaptil diffuser Feliway friends
group diffuser group
Total participants per group 17 17
Number of pets per household
Multi-cat household 11 9
Multi-dog household 7 6
Multiple cats AND multiple dogs 6 3
in household
Sex of pets
Dogs—Female: Male 5:12 7:10
Cats—Female: Male 7:10 8:9
Neuter status
Both neutered 12 14
Entire dog/neutered cat 5 3
Entire cat 0 0
Style of cat-dog relationship
Dog interested; cat fearful 9 9




Work in animal related profession 16 13
Female: Male 17:0 16:1
TABLE 2 | Age and duration cohabiting of pets (years) in each treatment group.
Adaptil Feliway friends
Mean ± SD Median Mean ± SD Median
Age of dog 4.69 ± 3.94 3 4.62 ± 4.25 3.5
Age of cat 6.35 ± 3.02 7 6.91 ± 4.47 6
Duration of cohabitation 2.44 ± 2.40 1.5 2.65 ± 1.91 2.5
Undesirable Behaviors
BetweenWeeks 2 and 6,≥50% reduction in undesirable behavior
scores was seen in 8/17 (47%) participants receiving AdaptilTM
and 5/17 (29%) participants receiving Feliway FriendsTM. A
reduction ≥30% in undesirable behaviors was seen in 12/17
(71%) participants in both groups.
Total undesirable interaction scores significantly differed
across the weeks F(3.3, 105.3) = 21.086, p < 0.001, η
2
p = 0.397;
there was no significant difference between the diffusers F(1, 32)
= 0.61, p = 0.440, η2p = 0.02, and no significant interaction
between week and diffuser group was observed F(3.3, 105.3) =
0.832, p = 0.488, η2p = 0.025. Post hoc pairwise comparisons
showed that there was no difference between Weeks 1 and 2
(baseline period), but that both of these weeks differed from each
of Weeks 3–6 (treatment period, all P ≤ 0.001).
The data relating to the specific behaviors making up the
undesirable interaction score, at baseline (week 2) and at the
end of the trial (week 6) are illustrated in Figure 1 below
(full dataset available in Supplementary Material Table 3). For
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those who received AdaptilTM, there was a significant decrease
in: dog chasing cat/cat runs away (Wilcoxon T = 4.5, p =
0.034); cat hiding from dog (T = 3.5, p = 0.012); cat/dog
staring at the other (T = 3.5, p = 0.012); and dog barking
at cat (T = 0, p = 0.046). For those receiving Feliway
FriendsTM, there was a significant decrease in the same behaviors:
dog chasing cat/cat runs away (T = 3.5, p = 0.034); cat
hiding from dog (T = 0, p = 0.026); cat/dog staring at the
other (T = 0, p = 0.014); and dog barking at cat (T = 0,
p= 0.014).
Baseline individual undesirable behavior frequency scores did
not differ significantly from each other (i.e., Week 1 vs. Week 2
for each of the 10 undesirable behaviors, all P > 0.1).
TABLE 3 | Mean ± standard deviation total desirable and undesirable interaction
scores by week.
Week Adaptil Feliway friends
Desirable Undesirable Desirable Undesirable
1 3.65 ± 2.57 8.94 ± 5.93 5.24 ± 4.84 11.41 ± 5.28
2 3.54 ± 2.12 8.76 ± 5.38 5.00 ± 4.21 10.00 ± 5.91
3 4.24 ± 2.82 6.24 ± 5.65 5.47 ± 3.88 7.53 ± 4.89
4 4.53 ± 2.70 6.18 ± 4.71 5.88 ± 3.88 6.59 ± 4.60
5 4.53 ± 2.55 5.76 ± 4.84 6.59 ± 4.73 7.24 ± 3.90
6 4.41 ± 2.32 5.29 ± 5.18 7.06 ± 5.13 5.88 ± 4.65
Difference 0.88 ± 2.14 −3.47 ± 3.87 2.06 ± 3.73 −4.12 ± 4.04
Week 6–2
Shaded rows represent baseline period, bold row describes difference between last
baseline week (Week 2) and last week of treatment (Week 6).
Desirable Behaviors
Between Weeks 2 and 6, ≥50% increase in desirable interaction
scores was seen in 6/17 (35%) participants receiving AdaptilTM
and 8/17 (47%) participants receiving Feliway FriendsTM.
A≥ 30% increase in desirable interaction scores was seen in 8/17
(47%) of participants in both groups.
Total desirable interaction scores differed significantly across
the weeks F(3.531, 112.990) = 4.281, p < 0.01, η
2
p = 0.118. No
significant difference was observed between the two diffuser types
F(1, 32) = 2.456, p = 0.127, η
2
p = 0.071, and no significant
interaction between week and diffuser group was observed
F(3.531, 112.990) = 0.763, p = 0.537, η
2
p = 0.023. Post hoc pairwise
comparisons did not detect significant differences between any
specific pairs of weeks, however analysis of within-subject
contrasts showed a significant linear relationship between Week
and desirable behavior score F(1, 32) = 11.231, p <0.01, η
2
p =
0.260, with a linear increase in total desirable interaction scores
fromWeek 1 to Week 6.
The data relating to the specific behaviors making up the
desirable interaction score, at baseline (week 2) and at the end
of the trial (week 6) are illustrated in Figure 2 below (full data
available in Supplementary Material Table 3). For those who
received AdaptilTM, there was a significant increase in: friendly
greeting (T= 15, Z=−2.121, p= 0.034) and frequency of times
spent relaxed in the same room (T = 32.5, Z = −2.126, p =
0.033). For those who received Feliway FriendsTM, none of the
individual desirable behaviors demonstrated a significant change
fromWeek 2 to Week 6.
Baseline individual desirable behavior frequency scores did
not differ significantly from each other (i.e., Week 1 vs. Week 2
for each of the seven desirable behaviors, all P > 0.1).
FIGURE 1 | Mean (± 95% confidence interval) behavior frequency scores for individual undesirable interactions at baseline (week 2) and end of trial (week 6).
Frequency scores as per Likert scale, 0 = not this week; 1 = once or twice this week; 2 = three to six times this week; 3 = daily; 4 = several times per day. *indicates
a significant difference (p < 0.05) between related week 2 and week 6 scores.
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FIGURE 2 | Mean (± 95% confidence interval) behavior frequency scores for individual desirable behaviors at baseline (week 2) and end of trial (week 6). Frequency
scores as per Likert scale, 0 = not this week; 1 = once or twice this week; 2 = three to six times this week; 3 = daily; 4 = several times per day. *indicates a
significant difference (p < 0.05) between related week 2 and week 6 scores.
TABLE 4 | Mean ± standard deviation cat and dog relaxation scores by week.
Week Adaptil Feliway friends
Cat relaxation Dog relaxation Cat relaxation Dog
relaxation
1 6.71 ± 1.21 7.94 ± 1.03 6.24 ± 1.95 7.59 ± 2.09
2 6.77 ± 1.56 7.77 ± 1.15 6.77 ± 1.86 7.47 ± 1.81
3 7.82 ± 1.13 8.24 ± 1.09 7.71 ± 1.65 8.18 ± 1.67
4 7.71 ± 1.16 8.29 ± 1.31 7.41 ± 1.94 8.35 ± 1.37
5 7.71 ± 1.45 8.18 ± 1.33 8.12 ± 1.17 8.77 ± 0.90
6 7.88 ± 1.32 8.29 ± 1.16 8.12 ± 1.69 8.59 ± 1.28
Difference 1.11 ± 1.73 0.52 ± 0.80 1.35 ± 1.87 1.12 ± 2.00
Week 6–2
Shaded rows represent baseline period, bold refers to last baseline vs. last treatment
week difference.
Cat and Dog Relaxation Scores (Table 4)
In the AdaptilTM treatment group there was no significant
(adjusted p < 0.025) difference in cat relaxation scores from
baseline (Week 2) to the end of the trial (Week 6) (T =
66.5, p = 0.028) but a significant difference was seen in dog
relaxation scores (T= 4.0, p= 0.021). Conversely, in the Feliway
FriendsTM treatment group there was no significant difference in
dog relaxation scores from baseline (Week 2) to the end of the
trial (Week 6) (T = 40.0, p = 0.037) but a significant difference
was found in cat relaxation scores between Week 2 and Week 6
(T= 71.0, p= 0.011).
DISCUSSION
There was a beneficial response to diffuser use with a significant
decrease in undesirable interaction scores and a significant
increase in desirable interaction scores across the trial period,
regardless of the specific product used. By contrast, improved
relaxation scores at the end of treatment compared to baseline,
were species-specific. Response to treatment appeared to be
rapid with the greatest decrease in undesirable behavior scores
occurring during the first week of diffuser use. Partial η2 values
of above 0.14 are traditionally considered large, so the effect of
the two treatments on undesirable behavior is very large, while
the effect on desirable behavior is medium.
There are two obvious possible interpretations of the absence
of a significant difference between the treatment groups in these
outcomes: either both groups were subject to a similar placebo
effect; or both diffuser products were similarly effective.
The placebo effect is greater when subjects are aware that
there is a higher likelihood of receiving an active treatment in
a trial, such as in comparative study designs like the current trial
(31). For example, in an analysis of 48 placebo-controlled vs. 42
comparator studies on human treatments for depression, a 15%
higher response rate for a particular medication was found in the
comparator trials (32). Even so, the high response rate seen in
the current trial, is beyond that expected for a placebo even in a
comparative trial (32). Steps were also taken in the current trial
to reduce owner subjectivity with the desirable and undesirable
interactions assessed from relatively objective measures of
observation frequency (from never to several times per day)
of specific events rather than with some form of subjective
rating scale. Further evidence against the results being those of
a placebo, comes from the differential effect reported on cat/dog
relaxation scores, which were consistent with predicted product-
specific effects. Thus, it seems that the common components to
these products affect the tendency for undesirable interactions,
but the species-specific elements may affect comfortability or
relaxation of the individual in the presence of another. This
hypothesis deserves further investigation.
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The two groups were well matched and thus the different
effects noted between the groups cannot be obviously attributed
to any demographic factor; so the difference in the products offers
the most parsimonious explanation.
Whilst it might be expected that Feliway FriendsTM would
be more effective in multi-species homes given the apparently
stronger contribution of the cat’s comfortability to the quality of
the cat-dog relationship (9), this did not appear to be the case.
Indeed, although there were no statistically significant differences
in effect between the products overall on either total undesirable
or desirable interaction scores, only the dog-specific product had
a significant effect on increasing specific desirable behaviors. We
suggest this apparent contradiction might be explained by the
behavior of the dog being the primary determinant of the cat’s
quality of interaction with it. For example, a more relaxed dog
may be less likely to disturb the cat (e.g., by chasing it), resulting
in a cat that is less stressed and more willing to form some form
of social bond with the dog, increasing the desirable interactions
perceived alongside a reduction in undesirable interactions.
By contrast a more relaxed cat may reduce the likelihood of
undesirable interactions, but not necessarily increase desirable
interaction so much as the dog may still engage in unacceptable
interactions from the cat’s perspective, even if they are playful
from the dog’s perspective and seen as acceptable by the owner.
This is in keeping with the demographic split in this study, which
showed that over half of the relationships at baseline could be
described as “dog interested—cat fearful.” It is likely that the cat’s
comfortability is indeed important, but that excessive interest
from the dog may prohibit the cat from feeling comfortable
around him.
Relationship categories of amicable, aggressive or indifferent
have been suggested by Feuerstein and Terkel (7), but these
do not consider which is the aggressor/victim in “aggressive”
relationships, nor allow for relationships in which pets are
fearful, but actively avoid one another. For the purpose of this
study, descriptions of relationships were taken at induction and
relationships were grouped into four categories: dog interested—
cat fearful; cat interested—dog fearful; indifferent; and avoidant
(there were no purely amicable relationships as these would not
have met the inclusion criteria). Although ratios were similar
between groups (AdaptilTM 9:2:2:4 and Feliway FriendsTM
9:4:0:4) categorization was not straightforward: there was some
overlap between categories and variation in the style of the
behaviors described within categories. In particular, fearful
cats were typically described as running away or showing
aggressive behaviors such as hissing/ swiping, but often showed
combinations of both, preventing separation into fearful-flee and
fearful-aggressive categories. Nonetheless we propose that this
classification system provides a useful basis for future studies.
There is undoubtedly a need for more basic ethological research
to describe cat-dog interactions and how these might group into
particular styles of behavior, as has recently been done with
separation related problems in dogs (33).
From a practical clinical perspective, client perceptions
and feedback are very important, since they determine
both the size of the problem but also the feasibility of the
treatment. Overall, feedback from the trial was positive with
participants reporting that they found the experience enjoyable
and the survey straightforward to complete. Accordingly,
we suggest that the survey instrument developed here
(Supplementary Material Table 1) be used as a routine method
of monitoring homes with this problem. The subtle, unsolicited
observations of the behavior of pets in the home reported by
some clients were an unexpected bonus, which may also have
been facilitated by the use of the survey instrument to encourage
closer observation of the pets in the home.
Unfortunately, the survey item which asked participants to
decide whether the cat-dog relationship was “the same,” “better”
or “worse” than normal each week had to be excluded from
analysis as it was found to be ambiguous. The ambiguity arose
as it was not clear to some participants whether a consistent
improvement with no new changes from when the diffuser had
first been plugged in should be marked as “the same” (as the
previous week) or “better” (compared with baseline). For future
research it is advised to replace this item with a ten-point scale
rating of the quality of the relationship each week, such that
changes in the relationship across previous weeks do not impact
the participant’s rating.
It would be useful to further study the efficacy of these
pheromone products in multi-species households using
the revised survey instrument with a larger sample size
and a four-group set up, with two diffusers per household
comprising: placebo-placebo; placebo-AdaptilTM; placebo-
Feliway FriendsTM; AdaptilTM-Feliway FriendsTM. It is
possible that the use of both products together could increase
efficacy since each product has a different composition and, as
demonstrated here, efficacy profile. There are no data that the
two products counteract each other, and the manufacturer says
both can be used in the home together.
Six participants (18%) subjectively reported no change at
all with the diffuser use, and these responses corresponded
quite well with the changes in undesirable behavior scores
seen, with five of these participants seeing <30% decrease in
undesirable behaviors: two had small decreases in undesirable
behavior scores, two had no change at all, and one reported a
slight increase in undesirable behaviors. Reviewing participant
information for these individuals did not reveal any unequivocal
predictive factor, although it should be noted that five of the
six (83%) were multi-cat households, whereas only 15 out of
the other 28 (54%) of the other households had multiple cats.
A predominance of multi-cat households in this study obscured
the ability to detect changes in a specific cat-dog relationship,
as cat-cat interactions are likely to also have impacted on cat-
dog interactions and vice versa. This may however be more
representative of the more common situation encountered in
practice where multi-cat and multi-dog households are common.
The cat-dog relationships were classified as “dog interested, cat
fearful” in five cases of these poor responders (83%) and while
this was the most commonly reported relationship it had a
prevalence of just 46% (13/28) among the remaining participants,
the other case was classified as “avoidant” and thus had a similar
prevalence to the remaining population (1/6= 17%, 7/28= 25%).
Further research using larger sample sizes to potentially tease out
predictive effects is warranted.
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Unsolicited qualitative feedback provided a further richness
to the data that helps understand the effect. In this regard
comments like: “less chasing and more gentle play”; “my dog
was his usual pesky self but the cats were much more chilled
with each other and with him”; “the whole household has been
more content,” are very consistent with the idea that the chemical
signal provides increased reassurance within the environment to
the subjects, are non-sedating and not simply anxiolytic like a
pharmacological agent.
CONCLUSION
Feliway FriendsTM and AdaptilTM both improved cat-dog
relationships in multi-species households. Although careful
attention to the exact interactions affecting the relationship
may help to determine the appropriate product, this appears
to be of marginal clinical relevance in most cases. From a
practical perspective, the evidence suggests that, in the absence
of detailed behavioral assessment either appeasing pheromone
diffuser product may be used with reasonable expectations
of success in multi-species households experiencing tension
between subjects. Further study is warranted to assess whether
both products could be used together to maximize efficacy since
each product has a different formulation and there is no evidence
of the two products counteracting each other.
DATA AVAILABILITY STATEMENT
All datasets presented in this study are included in the
article/Supplementary Material.
ETHICS STATEMENT
The study was reviewed and approved by the delegated authority
for MSc research of the University of Lincoln’s College of
Science Ethics Committee. The patients/participants provided
their written informed consent to participate in this study and
their comments to be quoted anonymously.
AUTHOR CONTRIBUTIONS
MP and DM contributed conception and design of the study.
MP collected all data, performed the statistical analysis, and
wrote the first draft of the manuscript. DM wrote sections
of the manuscript and developed the statistical analysis plan.
All authors contributed to the article and approved the
submitted version.
FUNDING
Ceva Animal Health provided the products free of charge without
any restriction on their use or involvement in either design,
execution or publishing the work. They have subsequently offered
to pay for the work to be made available open access.
ACKNOWLEDGMENTS
We would like to thank Julia Pounder of the University
of Lincoln for independently assigning treatments their
numbers and ensuring the authors remained blinded to
treatment throughout. Our thanks to Heinz and Sara
Meyer for their assistance with website design, Hilary
and Michael Kaltz and Carol, John and Jonathan Prior
for reading earlier drafts of this work and staff at the
Veterinary Hospital, Lincoln, for facilitating the research within
their practice.
SUPPLEMENTARY MATERIAL




1. Pfma.org.uk. Pet Population 2017. (2019). Available online at:
https://www.pfma.org.uk/pet-population-2017 (accessed May
1, 2019).
2. Clancy EA, Rowan AN. Companion animal demographics in the
United States: a historical perspective. In: Salem DJ, Rowan AN, editors.
The State of the Animals II: 2003. Washington, DC: Humane Society Press
(2003). p. 9–26.
3. Drews C. Wild Animals and Other Pets Kept in Costa
Rican Households: Incidence, Species and Numbers.
Soc Anim. (2001) 9:107–26. doi: 10.1163/1568530017536
39233
4. Toribio J, Norris JM, White JD, Dhand NK, Hamilton SA, Malik R.
Demographics and husbandry of pet cats living in Sydney, Australia: results of
cross-sectional survey of pet ownership. J Feline Med Surg. (2009) 11:449–61.
doi: 10.1016/j.jfms.2008.06.010
5. Slater MR, Di Nardo A, Pediconi O, Villa PD, Candeloro L, Alessandrini
B, et al. Cat and dog ownership and management patterns in central
Italy. Prev Vet Med. (2008) 85:267–94. doi: 10.1016/j.prevetmed.2008.
02.001
6. Murray JK, Gruffydd-Jones TJ, Roberts MA, Browne WJ. Assessing changes
in the UK pet cat and dog populations: numbers and household ownership.
Vet Rec. (2015) 177:259. doi: 10.1136/vr.103223
7. Feuerstein N, Terkel J. Interrelationships of dogs (Canis familiaris) and cats
(Felis catus L.) living under the same roof. Appl Anim Behav Sci. (2008)
113:150–65. doi: 10.1016/j.applanim.2007.10.010
8. Bradshaw J. Sociality in cats: a comparative review. J Vet Behav. (2016)
11:113–24. doi: 10.1016/j.jveb.2015.09.004
9. Thomson J, Hall S, Mills D. Evaluation of the relationship between
cats and dogs living in the same home. J Vet Behav. (2018) 27:35–40.
doi: 10.1016/j.jveb.2018.06.043
10. Salman MD, Hutchison J, Ruch-Gallie R, Kogan L, New JC, Kass PH, et al.
Behavioral reasons for relinquishment of dogs and cats to 12 shelters. J Appl
AnimWelfare Sci. (2000) 3:93–106. doi: 10.1207/S15327604JAWS0302_2
11. Mills DS, Dube MB, Zulch H. Stress and Pheromonatherapy in Small Animal
Clinical Behaviour. Chichester: Wiley-Blackwell (2013).
12. Ceva United Kingdom. Companion animals / Products / Ceva
United Kingdom. (2019). Available online at: https://www.ceva.co.uk/
Products/Companion-animals (accessed May 1, 2019)
13. Pageat P, Gaultier E. Current research in canine and feline pheromones. Vet
Clin N Am. (2003) 33:187–211. doi: 10.1016/S0195-5616(02)00128-6
Frontiers in Veterinary Science | www.frontiersin.org 9 July 2020 | Volume 7 | Article 399
Prior and Mills Pheromone Use in Cat-Dog Households
14. Tod E, Brander D,WaranN. Efficacy of dog appeasing pheromone in reducing
stress and fear related behaviour in shelter dogs. Appl Anim Behav Sci. (2005)
93:295–308. doi: 10.1016/j.applanim.2005.01.007
15. Gaultier E, Bonnafous L, Bougrat L, Lafont C, Pageat P. Comparison of the
efficacy of a synthetic dog-appeasing pheromone with clomipramine for the
treatment of separation-related disorders in dogs. Vet Rec. (2005) 156:533–8.
doi: 10.1136/vr.156.17.533
16. Levine ED, Ramos D, Mills DS. A prospective study of two self-help
CD based desensitization and counter-conditioning programmes with the
use of Dog Appeasing Pheromone for the treatment of firework fears
in dogs (Canis familiaris). Appl Anim Behav Sci. (2007) 105:311–29.
doi: 10.1016/j.applanim.2006.11.006
17. Mills DS, RamosD, EstellesMG,Hargrave C. A triple blind placebo-controlled
investigation into the assessment of the effect of Dog Appeasing Pheromone
(DAP) on anxiety related behaviour of problem dogs in the veterinary clinic.
Appl Anim Behav Sci. (2006) 98:114–26. doi: 10.1016/j.applanim.2005.08.012
18. Denenberg S, Landsberg G. Effects of dog-appeasing pheromones on anxiety
and fear in puppies during training and on long-term socialization. J Am Vet
Med Assoc. (2008) 233:1874–82. doi: 10.2460/javma.233.12.1874
19. Frank D, Beauchamp G, Palestrini C. Systematic review of the use of
pheromones for treatment of undesirable behavior in cats and dogs. J Am Vet
Med Assoc. (2010) 236:1308–16. doi: 10.2460/javma.236.12.1308
20. Yeates J, Everitt S, Innes JF, Day MJ. Ethical and evidential
considerations on the use of novel therapies in veterinary
practice. J Small Anim Pract. (2013) 54:119–23. doi: 10.1111/jsap.
12031
21. Hewson C. Evidence-based approaches to reducing in-patient stress–
Part 2: synthetic pheromone preparations. Vet Nurs J. (2014) 29:204–6.
doi: 10.1111/vnj.12140
22. Pageat P, Cozzi A, Lecuelle C. Questions methods used in review
of pheromone treatments. J Am Vet Med Assoc. (2010) 237:624.
doi: 10.2460/javma.237.6.624
23. Beck A. Questions study on the use of pheromones in dogs and
cats. J Am Vet Med Assoc. (2010) 237:493. doi: 10.2460/javma.237.
5.493
24. DePorter T. Case report: role of cat appeasing pheromone in the resolution
of conflict between familiar felines. In: 18th Annual Meeting of the ESVCE
European Society of Veterinary Clinical Ethology, Avignon, (2011).
25. DePorter T, Bledsoe D, Beck A, Ollivier E. Evaluation of the efficacy of an
appeasing pheromone diffuser product vs placebo for management of feline
aggression in multi-cat households: a pilot study. J Feline Med Surg. (2018)
21:293–305. doi: 10.1177/1098612X18774437
26. Ceva. Cat Appeasing, Pheromone Feliway Friends and Technical Reference
Guide. 1st ed. Libourne: Ceva Sante Animale (2016).
27. Fowler FJ Jr, Fowler FJ. Improving Survey Questions: Design and Evaluation.
Applied Social Research Methods Series, Vol. 38. Thousand Oaks, CA: Sage
(1995). p. 132.
28. Brantmeier C. Statistical Procedures for Research on L2 Reading
Comprehension: An Examination of ANOVA and Regression Models.
Reading in a Foreign Language (2004). Available online at: https://files.eric.
ed.gov/fulltext/EJ689117.pdf (accessed March 5, 2019).
29. Misangyi V, LePine J, Algina J, Goeddeke F. The adequacy of repeated-
measures regression for multilevel research. Org Res Methods. (2006) 9:5–28.
doi: 10.1177/1094428105283190
30. Feise RJ. Do multiple outcome measures require p-value adjustment? BMC
Med Res Methodol. (2002) 2:8. doi: 10.1186/1471-2288-2-8
31. Enck P, Klosterhalfen S, Weimer K, Horing B, Zipfel S. The placebo response
in clinical trials: more questions than answers. Philos Transac R Soc Biol Sci.
(2011) 366:1889–95. doi: 10.1098/rstb.2010.0384
32. Rutherford B, Sneed J, Roose S. Does study design influence outcome?
Psychother Psychos. (2009) 78:172–81. doi: 10.1159/000209348
33. de Assis LS, Matos R, Pike TW, Burman OH, Mills DS. Developing
diagnostic frameworks in veterinary behavioral medicine: disambiguating
separation related problems in dogs. Front Vet Sci. (2020) 6:499.
doi: 10.3389/fvets.2019.00499
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Prior andMills. This is an open-access article distributed under the
terms of the Creative Commons Attribution License (CC BY). The use, distribution
or reproduction in other forums is permitted, provided the original author(s) and
the copyright owner(s) are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Veterinary Science | www.frontiersin.org 10 July 2020 | Volume 7 | Article 399
